ScienceGate
Advanced Search
Author Search
Journal Finder
Blog
Sign in / Sign up
ScienceGate
Search
Author Search
Journal Finder
Blog
Sign in / Sign up
Phase II clinical trial on docetaxel in the treatment of non-small-cell lung cancer (NSCLC)
Journal of Clinical Oncology
◽
10.1200/jco.2005.23.16_suppl.7352
◽
2005
◽
Vol 23
(16_suppl)
◽
pp. 7352-7352
Author(s):
Y. Chen
◽
Y. Zhao
◽
Z. Chen
◽
M. Liao
Keyword(s):
Lung Cancer
◽
Clinical Trial
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase Ii Clinical Trial
◽
Small Cell Lung
Download Full-text
Related Documents
Cited By
References
Phase II clinical trial of didemnin B in previously treated small cell lung cancer
Investigational New Drugs
◽
10.1007/bf00873966
◽
1994
◽
Vol 12
(3)
◽
pp. 243-249
◽
Cited By ~ 26
Author(s):
Dong M. Shin
◽
Paul Y. Holoye
◽
Arthur Forman
◽
Rodger Winn
◽
Roman Perez-Soler
◽
...
Keyword(s):
Lung Cancer
◽
Clinical Trial
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase Ii Clinical Trial
◽
Didemnin B
◽
Small Cell Lung
◽
Previously Treated
Download Full-text
Abstract CT152: Phase II clinical trial results for 4-demethyl-4-cholesteryloxycarbonyl-penclomedine (DM-CHOC-PEN) in advanced non-small cell lung cancer (NSCLC) involving the CNS
10.1158/1538-7445.am2021-ct152
◽
2021
◽
Author(s):
Roy S. Weiner
◽
Lee Roy Morgan
◽
Marcus Ware
◽
Tallat Mahmood
◽
Craig Gordon
◽
...
Keyword(s):
Lung Cancer
◽
Clinical Trial
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase Ii Clinical Trial
◽
Small Cell Lung
◽
Clinical Trial Results
Download Full-text
Abstract 4664: Result of TORI L-03, a randomized, multicenter phase II clinical trial of erlotinib (E) or E + fulvestrant (F) in previously treated advanced non-small cell lung cancer (NSCLC).
10.1158/1538-7445.am2013-4664
◽
2013
◽
Cited By ~ 7
Author(s):
Edward B. Garon
◽
Jill M. Siegfried
◽
Steven M. Dubinett
◽
Robert M. Elashoff
◽
David J. Park
◽
...
Keyword(s):
Lung Cancer
◽
Clinical Trial
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase Ii Clinical Trial
◽
Small Cell Lung
◽
Multicenter Phase
◽
Previously Treated
Download Full-text
Tolerability of a combination of carboplatin and etoposide phosphate in elderly patients with small cell lung cancer. A multicentric phase II clinical trial
Lung Cancer
◽
10.1016/s0169-5002(00)80131-2
◽
2000
◽
Vol 29
(1)
◽
pp. 41
◽
Cited By ~ 3
Author(s):
E Quoix
◽
J.L Breton
◽
C Daniel
◽
P Jacoulet
◽
D Debieuvre
◽
...
Keyword(s):
Lung Cancer
◽
Clinical Trial
◽
Elderly Patients
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase Ii Clinical Trial
◽
Small Cell Lung
◽
Etoposide Phosphate
Download Full-text
Phase II Clinical Trial of Lobaplatin (D-19466) in Pretreated Patients with Small-Cell Lung Cancer
Oncology Research and Treatment
◽
10.1159/000218823
◽
1996
◽
Vol 19
(4)
◽
pp. 328-332
◽
Cited By ~ 6
Author(s):
H.H. Fiebig
◽
H. Henß
◽
I. von Pawel
◽
U. Gatzemeier
◽
Ch. Manegold
◽
...
Keyword(s):
Lung Cancer
◽
Clinical Trial
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase Ii Clinical Trial
◽
Small Cell Lung
◽
Pretreated Patients
Download Full-text
C-kit protein expression in tumor specimens as a predictor of sensitivity to imatinib mesylate in patients with small cell lung cancer (SCLC): A phase II clinical trial
Journal of Clinical Oncology
◽
10.1200/jco.2004.22.14_suppl.7218
◽
2004
◽
Vol 22
(14_suppl)
◽
pp. 7218-7218
◽
Cited By ~ 1
Author(s):
L. M. Krug
◽
J. P. Crapanzano
◽
V. A. Miller
◽
C. G. Azzoli
◽
N. Rizvi
◽
...
Keyword(s):
Lung Cancer
◽
Clinical Trial
◽
Protein Expression
◽
Small Cell Lung Cancer
◽
Imatinib Mesylate
◽
Phase Ii
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase Ii Clinical Trial
◽
Small Cell Lung
Download Full-text
A phase II clinical trial of gemcitabine and imatinib mesylate for patients with recurrent non-small cell lung cancer (NSCLC)
Journal of Clinical Oncology
◽
10.1200/jco.2008.26.15_suppl.19101
◽
2008
◽
Vol 26
(15_suppl)
◽
pp. 19101-19101
Author(s):
M. Eleff
◽
M. A. Sovak
◽
D. Greenberg
◽
L. Guensch
◽
P. Joyce
◽
...
Keyword(s):
Lung Cancer
◽
Clinical Trial
◽
Small Cell Lung Cancer
◽
Imatinib Mesylate
◽
Phase Ii
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase Ii Clinical Trial
◽
Small Cell Lung
Download Full-text
Outcomes from a Phase II Clinical Trial Evaluating the Systemic (Abscopal) Response from the Addition of Local Radiation to Standard-of-Care Immunotherapy for Metastatic Non-Small Cell Lung Cancer
International Journal of Radiation Oncology*Biology*Physics
◽
10.1016/j.ijrobp.2019.06.1360
◽
2019
◽
Vol 105
(1)
◽
pp. E519
Author(s):
M.D. Mattes
◽
T.D. Eubank
◽
M. Almubarak
◽
A.P. Provenzano
◽
S. Wen
◽
...
Keyword(s):
Lung Cancer
◽
Clinical Trial
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Standard Of Care
◽
Small Cell
◽
Phase Ii Clinical Trial
◽
Small Cell Lung
◽
Local Radiation
Download Full-text
cis-platinum (DDP) and VP 16-213 (etoposide) combination chemotherapy for advanced non-small cell lung cancer. A phase II clinical trial
European Journal of Cancer and Clinical Oncology
◽
10.1016/0277-5379(84)90080-4
◽
1984
◽
Vol 20
(3)
◽
pp. 347-351
◽
Cited By ~ 10
Author(s):
P.S. Mitrou
◽
M. Graubner
◽
W.E. Berdel
◽
S. Mende
◽
C. Gropp
◽
...
Keyword(s):
Lung Cancer
◽
Clinical Trial
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Combination Chemotherapy
◽
Small Cell
◽
Phase Ii Clinical Trial
◽
Small Cell Lung
Download Full-text
18 A multi-center, phase II clinical trial of genexol(paclitaxel) and cisplatin in patients with non-small cell lung cancer
Lung Cancer
◽
10.1016/s0169-5002(03)92709-7
◽
2003
◽
Vol 41
◽
pp. S278-S279
Author(s):
Hoon-Kyo Kim
◽
Se-Hoon Lee
◽
Keunchil Park
◽
Cheolwon Suh
◽
Jun-Suk Kim
◽
...
Keyword(s):
Lung Cancer
◽
Clinical Trial
◽
Small Cell Lung Cancer
◽
Phase Ii
◽
Cell Lung Cancer
◽
Small Cell
◽
Phase Ii Clinical Trial
◽
Small Cell Lung
Download Full-text
Sign in / Sign up
Close
Export Citation Format
Close
Share Document
Close